HealthNews

More than 140,000 bottles of cholesterol medication part of elevated recall

A major recall of thousands of bottles of medication has been upgraded to a higher risk level.

In September, a U.S. Food and Drug Administration Enforcement Report announced that Ascend Laboratories was recalling 141,984 bottles of its Atorvastatin Calcium Tablets, a medication used to lower cholesterol. The recall is due to “failed dissolution specifications,” which is when a drug does not dissolve the way it was supposed to during laboratory testing.

However, as of October 10, the recall was declared a Class II, which is a situation “in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,” per FDA.

See also  Trump reportedly to back ceding of Ukrainian territory to Russia as part of peace deal | Donald Trump

The recall affects tablets which were distributed nationwide, in 90-count, 500-count, and 1,000-count bottles. Bottles have Expiration Dates up to February 2027.

Recalled tablets can also be identified by specific lot numbers, which can be found here.

The medication was recalled because it did not dissolve properly during labratory testing (Getty Images)

When dissolution of a medication fails, it means the drug may not be “available for the body to absorb,” per the FDA.

However, there weren’t any reported illnesses.

According to Yale Medicine, 47 million Americans take cholesterol medication each day. Usually, the medication is “a statin, a pill that has a powerful impact on keeping the heart healthy.” A statin can “help to clear it away and reduce the amount” of cholesterol, also known as waxy substance, in the blood.

“This keeps the cholesterol from leaving fatty deposits (called plaque) in the arteries, greatly reducing the risk of heart attack or stroke,” the medical site adds.

Meanwhile, other medications have been recalled this year. In June, Little Remedies Honey Cough Syrup was recalled over the “presence” of Bacillus cereus, a type of bacteria that can cause two types of foodborne illnesses, and because of “loss of shelf-stability.”

The recall described the symptoms associated with both foodborne illnesses. One can cause nausea, vomiting, and stomach cramps starting one to six hours after consuming contaminated food. The second illness can cause stomach cramps and diarrhea starting 8 to 16 hours after exposure.

“Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death,” the recall notice warned at the time.

See also  Inside Nigeria’s Amazon Clinic, run by a traditional birth attendant selling unapproved herbal mixtures

The popular cough syrup was sold by retailers throughout the country and online from December 14, 2022, to June 4, 2025. However, there were no serious adverse effects reported because of the recall.


Source link

Back to top button
close